Introduction
Status epilepticus (SE) is a neurological emergency associated with a high morbidity and mortality. 1 In industrialized countries with Caucasian populations, the incidence of SE ranges from 9.9 to 41/100,000/year, 2-6 with a higher incidence in patients older than 60 years (54-86/100,000/year); this high variability is partially related to the different criteria used to diagnose SE. [7] [8] [9] According to Shorvon, 10 one of the most complete definitions of SE, based on both clinical and neurophysiological findings, is: ''a condition in which epileptic activity persists for 30 minutes or more, causing a wide spectrum of clinical symptoms and with a highly variable pathophysiological, anatomical and aetiological basis''. Hospitalization, accompanied by both clinical and neurophysiological investigations, of patients suspected of having SE is thus warranted to promptly diagnose this condition and provide optimal management.
proposed a prognostic score (Status Epilepticus Severity Score -STESS) based on four outcome predictors determined before administration of treatment: age with a 65-year cut-off, previous history of seizures, seizure type and extent of consciousness impairment. A scrupulous evaluation of SE outcome predictors might help to select the most appropriate treatment strategies for each patient. SE treatment protocols recommend a wide range of drug intensities, including small doses of benzodiazepines, combinations of intravenously administered antiepileptic drugs and coma-induction with appropriate anesthetic agents. 18 In 2006, a SE subcommission of the Guidelines Commission of the Italian League against Epilepsy drew up the guidelines for the management of SE in adults. 9 Although all the guidelines refer to convulsive, tonic-clonic generalized SE management, they may be extended to the treatment of every type of SE in clinical practice. The aim of this study is to provide a report of a 3-year study on the diagnosis and management of SE, conducted in our university hospital, based on an analysis of the patients' demographic data, SE type, response to AED treatment and outcome.
Materials and methods
We conducted a 3-year prospective study for which we enrolled consecutive adult inpatients at the Policlinico Umberto I Hospital (Sapienza University of Rome), between January 1st 2007 and December 31st 2009. All the patients, who had been admitted to the emergency room or were already hospitalized in other medical and surgical divisions, were diagnosed as having SE, according to the clinical presentation and EEG findings. Our laboratory is the only emergency EEG Service at the Policlinico Umberto I University Hospital that is open 6 days a week, 12 hours a day. The hospital, which is located in the centre of Rome, has a secondary level emergency department to which patients with suspected neurological emergency conditions are electively transferred from the surrounding areas. Exclusion criteria were: patients < 18 years old; patients admitted overnight or on Sundays and treated for SE without an EEG recording. Patients received the best clinical treatment for the underlying disease, while the instrumental diagnosis included cerebral neuroimaging with CT or MRI.
EEG execution
An EEG with electro-cardiography (ECG) and electromyography (EMG) was performed with a digital apparatus (Micromed, Italy) and sampled at rate of 256 Hz. The following conventional chloride disc electrodes were applied on the scalp, according to the International 10-20 System: Fp2, Fp1, T4, T3, C4, C3, O2 and O1. After SE was diagnosed, the EEG recording was continued throughout the pharmacological treatment and for at least 30 min after resolution of the SE. In patients in whom the SE did not resolve, the EEG was performed again daily or upon request for clinical reasons.
SE antiepileptic treatment
According to the Italian guidelines for SE management, 9 treatment was administered using 4 standardized protocols, applied successively according to temporal parameters and the patient's response to AED drugs; each subsequent protocol was only applied if the previous protocol proved unsuccessful. The temporal parameters were: initial SE (within 30 min), established SE (within 90 min) and refractory SE (after 90 min). Protocol 1 for initial SE was based on lorazepam (0.05-0.1 mg/kg i.v. -maximum infusion rate 2 mg/min) or diazepam (0.1 mg/kg/i.v. -in 60 s). Protocol 2 for established SE was based on phenytoin (15-18 mg/kg i.v. at a maximum infusion rate of 50 mg/min). Protocol 3 for refractory SE was based on thiopental (5-7 mg/kg i.v. in 20 s followed by boluses at intervals of 2-3 min) or propofol (2-5 mg/kg i.v. bolus followed by continuous infusion up to 5 mg/kg/h). Administration of thiopental or propofol required the assistance of an anesthesiologist. Protocol 4, which was reserved for alternative therapies when previous drugs were ineffective or contraindicated, was based on sodium valproate (15 mg/kg i.v. over 5 min followed by 1-2 mg/kg/h as a continuous infusion, depending on the clinical response), midazolam (0.1-0.3 mg/kg as i.v. bolus, at a maximum infusion rate of 4 mg/min) and phenobarbital (10-20 mg/kg i.v. infused over 10 min -50-75 mg/ min). From 2008 onwards, intravenously administered levetiracetam (20 mg/kg i.v. infused over 15 min) was also used. 19 To assess the response to therapy, EEG monitoring was performed throughout AED treatment in order to follow cortical electrical activity modifications, as well as for at least one hour after seizure activity cessation. We considered the treatment effective when the complete resolution of epileptic discharges was observed and persisted for at least 30 min after the end of treatment. Since patients were hospitalized in the Intensive Care Unit or other emergency departments, subsequent neurophysiological testing was performed daily or upon request for clinical reasons.
SE classification
The following data were analysed in all the patients: (1) demographic data (age, sex), with age being considered both by adopting a cut-off of 65 years, as generally reported in the literature, and as a continuous variable; (2) SE clinical type: convulsive (CSE) and non-convulsive (NCSE), according to the clinical neurological presentation (presence of focal neurological symptoms -i.e. positive or negative-, localized or diffuse movement disorders -i.e. clonic, tonic-clonic or myoclonia-, eyelid myoclonia, lack of response to simple commands, autonomic dysfunction and cognitive/consciousness alterations); (3) SE EEG features: focal (F-SE) or generalized (G-SE) epileptic discharges; (4) electro-clinical correlations, considering both points (2) and (3): non-convulsive focal and generalized SE (NCSE-F, NCSE-G), convulsive focal or generalized SE (CSE-F, CSE-G); (5) etiology of SE according to instrumental findings, neuroimaging study (cerebral CT and/or MRI scan) and/or blood examinations and classified as: (a) lesional SE, (b) primary epileptic SE, (c) toxic metabolic SE or (d) anoxic SE; (6) response to antiepileptic treatment protocols 1, 2, 3 or 4; (7) clinical outcome after 30 days as: (a) good (return to normal daily activities), (b) poor (persistence of neurological deficit) and (c) death.
Statistical analysis
Data are presented in raw numbers. Data were analysed using SPSS 16 for Macintosh. x 2 and cross tabulation tables were used to compare differences in categorical variables. Student's t-test and ANOVA were used to determine differences between continuous variables in the categorical classes. Post-hoc analysis with Bonferroni's correction and Scheffè tests were used to determine multiple comparisons. Statistical significance was set at p < 0.05.
Results
Over a period of 3 years, we identified 56 patients with SE, 29 of whom were men and 27 women, with a mean age of 64.05 AE 20.4 years. The EEG was performed within 3.5 AE 2.8 h of the primary care physician's request. A full description of the population enrolled is provided in Table 1 .
Clinical SE type (CSE/NCSE) and EEG SE type (F-SE/G-SE): age and sex
As regards the clinical SE type, convulsive status epilepticus was observed in 35/56 patients and non-convulsive status epilepticus in the remaining 21/56 patients. As regards the SE type, no difference was observed for age when the cut-off was 65 years or gender. When age was considered as a continuous variable, patients with CSE were found to be significantly older than patients with NCSE (ANOVA: F = 4.616, p = 0.036).
As regards the EEG SE type, generalized SE was observed in 17/ 56 and partial SE in the remaining 39/56 patients. No difference was observed for gender. Patients with focal SE were older, both when a cut-off of 65 years was used (x 2 = 4.75, p = 0.03) and when age was considered as a continuous variable (ANOVA: F = 7.954, p = 0.007).
As regards the clinical and EEG SE type taken together, no differences were observed for sex or age when a cut-off of 65 years was adopted. When age was instead considered as a continuous variable, ANOVA revealed a significant difference for age between the four groups (ANOVA: F = 3.911, p = 0.014), with patients with focal SE (CSE or NCSE) being older. The data are summarized in Table 2 .
SE etiology
Lesional SE was observed in 37/56 patients, epileptic SE in 10/ 56 patients, toxic-dysmetabolic SE in 3/56 patients and anoxic SE in 6/56 patients. No differences were observed in gender as regards the SE etiology. A significant difference was observed for age and SE etiology, both when a cut-off of 65 years was adopted (x 2 = 9.056, p = 0.029) and when age was considered as a continuous variable (ANOVA: F = 5.715, p = 0.002): the oldest patients were those with lesional SE, followed by patients with anoxic SE and those with toxic dysmetabolic SE. Patients with epileptic SE were the youngest. Post-hoc analysis with Bonferroni's correction showed that the difference within groups was significant only in lesional vs epileptic patients (p = 0.001). The clinical and EEG data divided according to etiology are shown in Table 3 .
SE treatment
Thirty out of 56 patients displayed complete SE regression after being treated with protocol 1, 9/56 after protocols 1 + 2, 9/56 after protocols 1 + 2 + 3 while 8/56 needed protocol 4 to control epileptic activity. If we consider the type of SE according to the clinical classification (CSE vs NCSE), no difference emerged in the number of protocols needed to eliminate epileptic activity. If we consider the SE according to the EEG findings (F-SE and G-SE), a difference in response to treatment emerged, with protocol 1 most frequently proving to be sufficient to successfully treat F-SE (x 2 = 1.170, p < 0.009). As regards SE etiology, a difference in the response to treatment was observed (x 2 = 3.873, p < 0.000), with protocol 1 most frequently proving to be sufficient to successfully treat patients with lesional and epileptic SE, while protocols 3 or 4 were needed in all anoxic patients. The data are presented in Table  4 .
SE outcome
Outcome was good in 35/56 patients, poor in 12/56 patients, while 9/56 patients died. No difference was observed for sex and age either when a cut-off of 65 years was adopted or when age was considered as a continuous variable, though a trend toward a worse outcome and death did emerge in older patients. A significant difference was observed in outcome as regards the clinical SE type (x 2 = 9.09, p = 0.011), the EEG SE type (x 2 = 8.418, p < 0.015) and both (x 2 = 2.594, p < 0.000), with a better outcome emerging in CSE, F-SE and CSE-F. The data are shown in Table 5 . A significant difference was observed in outcome when patients were divided according to etiology (x 2 = 4.274, p = 0.000), with a better outcome being observed in epileptic SE and toxic SE patients, and a worse outcome in anoxic SE patients. As expected, a significant difference was observed between the different treatment protocols (x 2 = 2.332, p = 0.001), with those responding to protocol 1 having a better outcome than those requiring protocols 3 and 4.
Discussion
There is no universally accepted definition of SE in clinical studies. Traditionally, a diagnosis of SE, when convulsive, is based upon clinical evidence of repeated, clustering seizures, and may be easier to make than in the absence of clinical signs. 11 Indeed, when SE is non-convulsive, EEG-based evidence of epileptic activity is required to confirm a diagnosis that may only be suspected on the basis of clinical findings. 10 Therefore, when EEG is not available, NCSE may be suspected, though not confirmed, which highlights the importance of the role played by EEG in the diagnosis and management of SE. The diagnosis-related problems (i.e. clinical vs electro-clinical) may hamper the interpretation and comparison of results from different studies, since diagnostic criteria are not homogeneous. In our study, we characterized SE according to both its clinical presentation (convulsive or non-convulsive) and to the EEG findings (focal or generalized). Our data based on a clinical and electro-clinical evaluation confirm the widespread observation that clinically convulsive SE and patients with focal EEG alterations are older than those with non-convulsive SE and generalized EEG abnormalities. This observation is probably related to the etiology: brain damage (stroke or brain tumors) that induces ''lesional'' SE is typical of older patients. By contrast, patients with anoxic SE, generally secondary to cardiac arrest, and toxic dysmetabolic SE are generally younger than patients with brain lesions. As expected, epileptic subjects presenting a SE represented the youngest group of patients. SE is usually characterized by a significant short-term morbidity and mortality. Moreover, since SE is a neurological emergency, patient institutionalization and prompt medical treatment is recommended. 2, 18 Although there is a large consensus for an aggressive treatment of generalized convulsive SE, agreement is lacking as to what the proper management of NCSE should consist of. 20, 21 International guidelines for convulsive SE management suggest that benzodiazepines and phenytoin should be used as first-and second-line treatments, though the authors of some studies 22 have pointed out that as many as 35-45% of patients with SE may be unresponsive to these approaches.
However, it should be borne in mind that SE in those studies was considered in general terms, there being no distinction between the convulsive and non-convulsive types or the different etiologies.
In our patients, we observed a difference in the response to treatment only when SE was considered according to the EEG findings and etiology: protocol 1 (i.v. benzodiazepines) proved to more effectively control focal SE, which is more often observed in patients with a lesional or epileptic etiology. On the other hand, a more aggressive approach, requiring combined treatments or sedation in intensive care units, was required in anoxic patients, which probably reflects the more complex cardiovascular instability of such patients.
As regards outcome, it should be borne in mind that the underlying condition inducing the SE, rather than SE itself, may be the main reason for the high mortality rate, which is approximately 20%.
14 Previous studies have shown that older age and acute symptomatic etiology are related to the worst outcomes. 15 In this regard, a prognostic score (Status Epilepticus Severity Score -STESS) that takes into account age > 65 years, previous history of seizures, seizure type and extent of consciousness impairment has recently been proposed as an outcome measure in clinical practice.
17
Our study confirms the role of age in SE prognosis; interestingly, only a trend toward a significantly poorer prognosis emerged when age was considered as a continuous variable. This finding may be ascribed to the fact that the prognosis of SE is more closely related to its etiology than to the SE itself. To sum up, the prognosis was best in patients with CSE, particularly those with focal SE, in whom the etiology was epileptic or toxic and who only received first-line treatment, regardless of their age and gender. Previous studies have shown that myoclonic SE in anoxic encephalopathy is associated with a poor outcome and that treatment of SE does not generally influence the prognosis. 16 In our patients, more intensive treatment was associated with a poor outcome owing to the severity of the clinical conditions: the outcome in patients who responded to protocol 1 was better than that in patients who received protocols 3 and 4. This is, however, to be expected given that the clinical conditions of patients who require multiple aggressive approaches are evidently more complex.
Conclusions
The accurate characterization of SE is fundamental. A prompt neurophysiological EEG evaluation with continuous EEG monitoring, when available, combined with a clinical evaluation helps to make an accurate prognosis and select the most appropriate therapy. In lesional and epileptic SE, first-line treatments and subsequent periodical standard EEG may be sufficient to control the electro-clinical status, while intensive care unit management with a more aggressive therapeutic approach and continuous EEG monitoring are recommended for refractory SE. 
